| Financial Year |
March 31 2023 |
| Monetary Funds |
7,525,886,446.35 |
| Held-for-trading Financial Assets |
465,547,453.32 |
| Notes Receivable |
60,475,360.00 |
| Accounts Receivable |
8,886,258,012.69 |
| Advances to Suppliers |
5,682,922,560.90 |
| Other Receivables |
886,866,736.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,040,114.47 |
| Inventories |
3,064,779,275.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,127,706,235.50 |
| Other Current Assets |
244,149,362.98 |
| Total Current Assets |
35,847,241,778.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,121,341,221.98 |
| Long-term Equity Investment |
683,915,230.86 |
| Investment Properties |
658,117,750.07 |
| Fixed Assetes |
4,120,837,756.93 |
| Under-construction Projects |
1,006,632,681.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,116,059,346.22 |
| R&D expenses |
-- |
| Goodwill |
895,944,138.14 |
| Long-Term Deferred and Prepaid Expenses |
174,999,435.38 |
| Deferred Income Tax Assets |
546,131,251.48 |
| Other Non-Current Assets |
846,293,028.61 |
| Sub-Total of Non-Current Assets |
14,261,765,399.56 |
| Total Assets |
50,109,007,177.93 |
| Short-Term Loans |
2,368,941,836.14 |
| Trading Financial liabilities |
210,213.59 |
| Notes Payable |
2,590,345,162.72 |
| Accounts Payable |
10,481,906,496.89 |
| Accounts Received In Advance |
1,935,154.77 |
| Employee Compensation Payable |
354,451,696.18 |
| Taxes Payable |
492,740,157.36 |
| Interest Payable |
-- |
| Dividend Payable |
421,732,733.10 |
| Other payables |
2,493,617,046.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
788,476,139.72 |
| Other Current Liabilities |
855,134,902.94 |
| Sub-Total of Current Liabilities |
26,552,875,095.92 |
| Long-term Loans |
2,133,179,334.23 |
| Bonds Payable |
1,509,800,000.00 |
| Long-Term Accounts Payable |
74,557,244.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
168,508,491.75 |
| Deferred Income Tax Liabilities |
97,357,170.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,571,161,091.97 |
| Total Liabilities |
31,124,036,187.89 |
| Paid-In Capital(Or Share Stock) |
2,632,510,170.00 |
| Capital Surplus |
311,935,041.57 |
| Surplus Reserve |
976,748,193.92 |
| LESS:Treasury Stock |
267,191,920.55 |
| Undistributed Profits |
13,695,177,312.39 |
| Minority Stockholder's Interest |
1,440,636,342.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,544,334,647.86 |
| Owner's Equity（Stockholder's Equity） |
18,984,970,990.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
50,109,007,177.93 |
